Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1756-0500

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults ; volume:5 ; number:1 ; day:24 ; month:10 ; year:2012 ; pages:1-5 ; date:12.2012
BMC Research Notes / Biomed Central ; 5, Heft 1 (24.10.2012), 1-5, 12.2012

Creator: Dixon, Brian M.
Barker, Tyler
McKinnon, Toni
Cuomo, John
Frei, Balz
Borregaard, Niels
Gombart, Adrian F.

Contributor: SpringerLink (Online service)

DOI: 10.1186/1756-0500-5-575

URN: urn:nbn:de:101:1-2019101013324424980135

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:32 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Dixon, Brian M.
Barker, Tyler
McKinnon, Toni
Cuomo, John
Frei, Balz
Borregaard, Niels
Gombart, Adrian F.
SpringerLink (Online service)

Other Objects (12)

Circulating Antimicrobial Peptide LL-37 Status in Type 1 Diabetes Mellitus and its Relation with Glycemic Control

Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37

Recombinant production of human antimicrobial peptide LL- 37 and its secondary structure

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections

HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients

The impact of N-glycosylation on the properties of the antimicrobial peptide LL-III

Remodeling of the Fibrillation Pathway of α‐Synuclein by Interaction with Antimicrobial Peptide LL‐III

Remodeling of the fibrillation pathway of α-synuclein by interaction with antimicrobial peptide LL-III

Circulating 25-hydroxyvitamin D levels and hypertension risk after adjusting for publication bias

LL-37_Renalexin hybrid peptide exhibits antimicrobial activity at lower MICs than its counterpart single peptides

The antimicrobial effect of a novel peptide LL-1 on Escherichia coli by increasing membrane permeability

Activation of Eosinophils Interacting with Bronchial Epithelial Cells by Antimicrobial Peptide LL-37: Implications in Allergic Asthma

Circulating Antimicrobial Peptide LL-37 Status in Type 1 Diabetes Mellitus and its Relation with Glycemic Control

Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37

Recombinant production of human antimicrobial peptide LL- 37 and its secondary structure

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections

HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients

The impact of N-glycosylation on the properties of the antimicrobial peptide LL-III

Remodeling of the Fibrillation Pathway of α‐Synuclein by Interaction with Antimicrobial Peptide LL‐III

Remodeling of the fibrillation pathway of α-synuclein by interaction with antimicrobial peptide LL-III

Circulating 25-hydroxyvitamin D levels and hypertension risk after adjusting for publication bias

LL-37_Renalexin hybrid peptide exhibits antimicrobial activity at lower MICs than its counterpart single peptides

The antimicrobial effect of a novel peptide LL-1 on Escherichia coli by increasing membrane permeability

Activation of Eosinophils Interacting with Bronchial Epithelial Cells by Antimicrobial Peptide LL-37: Implications in Allergic Asthma

Circulating Antimicrobial Peptide LL-37 Status in Type 1 Diabetes Mellitus and its Relation with Glycemic Control

Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37

Recombinant production of human antimicrobial peptide LL- 37 and its secondary structure

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections

HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients

The impact of N-glycosylation on the properties of the antimicrobial peptide LL-III

Remodeling of the Fibrillation Pathway of α‐Synuclein by Interaction with Antimicrobial Peptide LL‐III

Remodeling of the fibrillation pathway of α-synuclein by interaction with antimicrobial peptide LL-III

Circulating 25-hydroxyvitamin D levels and hypertension risk after adjusting for publication bias

LL-37_Renalexin hybrid peptide exhibits antimicrobial activity at lower MICs than its counterpart single peptides

The antimicrobial effect of a novel peptide LL-1 on Escherichia coli by increasing membrane permeability

Activation of Eosinophils Interacting with Bronchial Epithelial Cells by Antimicrobial Peptide LL-37: Implications in Allergic Asthma

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Circulating Antimicrobial Peptide LL-37 Status in Type 1 Diabetes Mellitus and its Relation with Glycemic Control

Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37

Recombinant production of human antimicrobial peptide LL- 37 and its secondary structure

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections

HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients

The impact of N-glycosylation on the properties of the antimicrobial peptide LL-III

Remodeling of the Fibrillation Pathway of α‐Synuclein by Interaction with Antimicrobial Peptide LL‐III

Remodeling of the fibrillation pathway of α-synuclein by interaction with antimicrobial peptide LL-III

Circulating 25-hydroxyvitamin D levels and hypertension risk after adjusting for publication bias

LL-37_Renalexin hybrid peptide exhibits antimicrobial activity at lower MICs than its counterpart single peptides

The antimicrobial effect of a novel peptide LL-1 on Escherichia coli by increasing membrane permeability

Activation of Eosinophils Interacting with Bronchial Epithelial Cells by Antimicrobial Peptide LL-37: Implications in Allergic Asthma

Circulating Antimicrobial Peptide LL-37 Status in Type 1 Diabetes Mellitus and its Relation with Glycemic Control

Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37

Recombinant production of human antimicrobial peptide LL- 37 and its secondary structure

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections

HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients

The impact of N-glycosylation on the properties of the antimicrobial peptide LL-III

Remodeling of the Fibrillation Pathway of α‐Synuclein by Interaction with Antimicrobial Peptide LL‐III

Remodeling of the fibrillation pathway of α-synuclein by interaction with antimicrobial peptide LL-III

Circulating 25-hydroxyvitamin D levels and hypertension risk after adjusting for publication bias

LL-37_Renalexin hybrid peptide exhibits antimicrobial activity at lower MICs than its counterpart single peptides

The antimicrobial effect of a novel peptide LL-1 on Escherichia coli by increasing membrane permeability

Activation of Eosinophils Interacting with Bronchial Epithelial Cells by Antimicrobial Peptide LL-37: Implications in Allergic Asthma

Circulating Antimicrobial Peptide LL-37 Status in Type 1 Diabetes Mellitus and its Relation with Glycemic Control

Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37

Recombinant production of human antimicrobial peptide LL- 37 and its secondary structure

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections

HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients

The impact of N-glycosylation on the properties of the antimicrobial peptide LL-III

Remodeling of the Fibrillation Pathway of α‐Synuclein by Interaction with Antimicrobial Peptide LL‐III

Remodeling of the fibrillation pathway of α-synuclein by interaction with antimicrobial peptide LL-III

Circulating 25-hydroxyvitamin D levels and hypertension risk after adjusting for publication bias

LL-37_Renalexin hybrid peptide exhibits antimicrobial activity at lower MICs than its counterpart single peptides

The antimicrobial effect of a novel peptide LL-1 on Escherichia coli by increasing membrane permeability

Activation of Eosinophils Interacting with Bronchial Epithelial Cells by Antimicrobial Peptide LL-37: Implications in Allergic Asthma

Related objects

Reset password